Hummingbird Bioscience
Konrad Paszkiewicz has served as the Chief Technology Officer of Hummingbird Bioscience since October 2017. Dr. Paszkiewicz leads Hummingbird’s internal platform technologies, including mAbPredict, biomarker discovery and omics-technologies such as single-cell analysis and spatial transcriptomics, machine learning and high performance computing and IT infrastructure. Between 2016 and 2017 Dr. Paszkiewicz was Director of the Wellcome Trust Biomedical Informatics Hub and the Head of the Genomics Sequencing Facility at the University of Exeter, UK. Dr. Paszkiewicz holds an MSci in Physics and a PhD in Bioinformatics from Imperial College, London.
This person is not in any offices
Hummingbird Bioscience
1 followers
Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.